Citation Impact
Citing Papers
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
2013 Standout
Chemotherapy and Targeted Therapy for Women With Human Epidermal Growth Factor Receptor 2–Negative (or unknown) Advanced Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline
2014
Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging
2023 Standout
Breast cancer
2019 Standout
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update
2018 Standout
Cardiotoxicity of anthracycline agents for the treatment of cancer: Systematic review and meta-analysis of randomised controlled trials
2010
Automatic classification of MR scans in Alzheimer's disease
2008 Standout
Open-Label, Multicenter, Phase 3 Extension Study of the Safety and Efficacy of Donepezil in Patients With Alzheimer Disease
2001
Environmental and health effects of the herbicide glyphosate
2017 Standout
The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics
2011 Standout
Dexrazoxane
1998
The cholinergic hypothesis of Alzheimer's disease: a review of progress
1999 Standout
Psychiatric Morbidity in Dementia With Lewy Bodies: A Prospective Clinical and Neuropathological Comparative Study With Alzheimer’s Disease
1999
Alzheimer’s disease and the basal forebrain cholinergic system: relations to β-amyloid peptides, cognition, and treatment strategies
2002
Long-term efficacy and safety of donepezil in the treatment of Alzheimer’s disease: final analysis of a US multicentre open-label study
2000
Hallucinations in Parkinson's disease: Prevalence, phenomenology and risk factors
2000 Standout
Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges
2010 Standout
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
2016 Standout
Medial Temporal Lobe Atrophy and APOE Genotype Do Not Predict Cognitive Improvement upon Treatment with Rivastigmine in Alzheimer’s Disease Patients
2004
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria
2007 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
White matter lesions in the elderly: Pathophysiological hypothesis on the effect on brain plasticity and reserve
2008
Anthrazykline in der Krebstherapie
1997 Standout
Protecting against anthracycline‐induced myocardial damage: a review of the most promising strategies
2005
The clinical syndrome of Alzheimer's disease: aspects particularly relevant to clinical trials
2004
Chronic Health Conditions in Adult Survivors of Childhood Cancer
2006 Standout
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
2010 Standout
Cardiotoxicity of Chemotherapeutic Agents
2000
Suboptimal Baseline Serum Vitamin B12 Is Associated With Cognitive Decline in People With Alzheimer’s Disease Undergoing Cholinesterase Inhibitor Treatment
2018
Dose-finding study of docetaxel and doxorubicin in first-line treatment of patients with metastatic breast cancer
1999
Alzheimer's disease
2006 Standout
Systematic Overview of Warfarin and Its Drug and Food Interactions
2005 Standout
Is anti-cholinesterase therapy of Alzheimer’s disease delaying progression?
2001
Acetylcholinesterase Inhibitors: Pharmacology and Toxicology
2013 Standout
Risk of dementia in diabetes mellitus: a systematic review
2005 Standout
Role of Free Radicals in the Neurodegenerative Diseases
2001 Standout
Alzheimer's Disease
2004 Standout
Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron
2009 Standout
Free radicals and antioxidants in chemotherapyinduced toxicity
1997
Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial
2000
Mild cognitive impairment as a diagnostic entity
2004 Standout
Cholinesterase Inhibitors: A New Class of Psychotropic Compounds
2000
Recent Developments in the Drug Treatment of Alzheimer??s Disease
1999
Assessment and management of behavioral and psychological symptoms of dementia
2015 Standout
Pharmacokinetic-Pharmacodynamic Relationships of the Anthracycline Anticancer Drugs
2002
Late effects of childhood cancer therapy
2002
The current and future role of dexrazoxane as a cardioprotectant in anthracycline treatment: expert�panel�review
2004
Increased App Expression in a Mouse Model of Down's Syndrome Disrupts NGF Transport and Causes Cholinergic Neuron Degeneration
2006 Standout
A comprehensive review in current developments of benzothiazole-based molecules in medicinal chemistry
2014 Standout
Cardiotoxicity of cytotoxic drugs
2003
Comprehensive Review on Alzheimer’s Disease: Causes and Treatment
2020 Standout
Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment
2005 Standout
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
APOE ε4 allele predicts faster cognitive decline in mild Alzheimer disease
2008
Invited Review Cholinesterase inhibitors for Alzheimer’s disease therapy: from tacrine to future applications
1998
Exercise and Physical Activity for Older Adults
2009 Standout
Utility of dexrazoxane for the reduction of anthracycline-induced cardiotoxicity
2008
Cholinesterase inhibitors as Alzheimer's therapeutics (Review)
2019
Prevention of High-Dose Chemotherapy–Induced Cardiotoxicity in High-Risk Patients by Angiotensin-Converting Enzyme Inhibition
2006 Standout
Efficacy and safety of eptastigmine for the treatment of patients with Alzheimer’s disease
1999
ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context
2012 Standout
Disposition of a Single Dose of Warfarin in Healthy Individuals after Pretreatment with Metrifonate
1999
Validation of the NPI-Q, a Brief Clinical Form of the Neuropsychiatric Inventory
2000 Standout
Practice parameter: Management of dementia (an evidence-based review) [RETIRED]
2001 Standout
APOE-ɛ4 Carrier Status and Donepezil Response in Patients with Alzheimer’s Disease
2015
Complementary/Alternative Medicine Use in a Comprehensive Cancer Center and the Implications for Oncology
2000 Standout
Cardiac Toxicity in Breast Cancer Survivors: Review of Potential Cardiac Problems
2008
Cardioprotective interventions for cancer patients receiving anthracyclines
2011
Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group
2008 Standout
Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease: a meta-analysis.
2003
Physical Activity and Public Health in Older Adults
2007 Standout
Galantamine in AD
2000
Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease
1998
The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease
2018 Standout
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
2015 Standout
Efficient Total Synthesis of Novel Bioactive Microbial Metabolites
2008 StandoutNobel
2002 Update of Recommendations for the Use of Chemotherapy and Radiotherapy Protectants: Clinical Practice Guidelines of the American Society of Clinical Oncology
2002
Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
2012 Standout
Anthraquinones As Pharmacological Tools and Drugs
2016 Standout
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Cholinesterase inhibitors for Alzheimer's disease
2006 Standout
Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality
2005 Standout
Works of P. Cyrus being referenced
Multicenter randomized controlled clinical trial to evaluate cardioprotection of dexrazoxane versus no cardioprotection in women receiving epirubicin chemotherapy for advanced breast cancer.
1996
Efficacy of Metrifonate in Improving the Psychiatric and Behavioral Disturbances of Patients with Alzheimer's Disease
2001
4-42-05 Metrifonate: Potential therapy for Alzheimer's disease
1997
Metrifonate treatment of the cognitive deficits of Alzheimer's disease
1998
Metrifonate treatment of AD
1999